Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT
NCT ID: NCT06505759
Last Updated: 2025-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
36 participants
INTERVENTIONAL
2024-07-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus
NCT02985099
1.2% Rosuvastatin Gel As A Local Agent In Smokers With Chronic Periodontitis
NCT03043196
Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus
NCT02386020
Locally Delivered Aloe Vera Gel in the Treatment of Chronic Periodontitis Patients With Diabetes Mellitus
NCT02437747
Role of Herbal Immunomodulators in the Treatment of Chronic Periodontitis
NCT01997814
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Group I (Control)- 12 sites with Probing depth of ≥5mm treated with scaling and root planing alone.
2. Group II -12 sites with Probing depth of ≥5mm treated with scaling and root planing followed by placement of bromelain gel.
3. Group III -12 sites with Probing depth of ≥5mm treated with scaling and root planing followed by placement of chlorhexidine gel.
periodontal pack was placed and patient was recalled at 1week,4th week and 12th week
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GROUP 1-SRP alone
control group is treated with SRP alone
SRP
Scaling and root planing was done with ultra sonic and hand scaling
GROUP 2-0.2% BROMELAIN gel
test group is treated with bromelain gel
Bromelain gel
bromelain gel is prepared from bromelain capsules in laboratory
GROUP 3-0.2% CHLORHEXIDINE gel
test group is treated with chlorhexidine gel
chlorhexidine gel
chlorhexidine gel is prepared from mouth wash
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bromelain gel
bromelain gel is prepared from bromelain capsules in laboratory
chlorhexidine gel
chlorhexidine gel is prepared from mouth wash
SRP
Scaling and root planing was done with ultra sonic and hand scaling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having ≥20 teeth.
-.Patients with radiographic evidence of bone loss in atleast two teeth.
* Patients who are systematically healthy.
* Patients with localized pockets with probing depth of ≤ 5mm.
* Patients who are cooperative and able to attend the hospital for regular follow-up.
Exclusion Criteria
* Pregnant or lactating females.
* Use of systemic antibiotics in the past 6 months.
* Patient who are not willing to give a written informed consent
30 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Krishnadevaraya College of Dental Sciences & Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. NALLAGATLA VAMSI VENKATA KRISHNA SAI
Bengaluru, Karnataka, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dr. MLV Prabhuji
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-D012-147453
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.